CLINICAL TRIALS FOR HEPATOCELLULAR CARCINOMA: ARE WE REACHING THE MOST VULNERABLE PATIENTS?肝细胞癌的临床试验：我们是否正在触及最脆弱的患者？HPBIF2.42026-04-170PRE
Rural comprehensive cancer care: Qualitative analysis of current challenges and opportunitiesJOURNAL OF RURAL HEALTHIF2.72024-05-161OA
Humanized mice for preclinical efficacy evaluation of drugs targeting GARPCANCER RESEARCHIF16.62023-04-040PRE
ASO Visual Abstract: The Impact of Commission on Cancer Accreditation Status, Hospital Rurality, and Hospital Size on Quality Measure Performance RatesANNALS OF SURGICAL ONCOLOGYIF3.52022-02-100PRE
The Impact of Commission on Cancer Accreditation Status, Hospital Rurality and Hospital Size on Quality Measure Performance RatesANNALS OF SURGICAL ONCOLOGYIF3.52022-01-2322PRE
Referrals and Decision-Making Considerations Involved in Selecting a Surgeon for Rectal Cancer Treatment in the Midwestern United StatesDISEASES OF THE COLON & RECTUMIF3.72022-01-044PRE
Improving cancer care locally: Study of a hospital affiliate network modelJOURNAL OF RURAL HEALTHIF2.72021-12-139OA
Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysisEJSOIF2.92020-09-017OAAI
Commentary and Complementary Data to Add to Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer ResectionsANNALS OF SURGICAL ONCOLOGYIF3.52020-01-024OAAI
Hospital and Surgeon Selection for Medicare Beneficiaries With Stage II/III Rectal Cancer The Role of Rurality, Distance to Care, and Colonoscopy ProviderANNALS OF SURGERYIF6.42019-10-2518OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项